Literature DB >> 3346057

The effect of a community hypertension control program.

I Macías1, F del Collado, G Forte.   

Abstract

A hypertension detection and control program sponsored by the Pan-American Health Organization and the World Health Organization (PAHO/WHO) was carried out in an urban health district of Havana City, Cuba. A baseline (initial) survey was conducted on a random sample of the population (greater than or equal to 15 years of age) to assess the problem of hypertension in that community. Subsequently, we extended the program in the same area by taking the blood pressure of as many people as we could, and a health education program on hypertension was developed and implemented. All hypertensive persons were treated. We surveyed about 90% of the adult population (29,640) over a 5-year period. We then conducted a final survey on a second random sample of the population to assess the effect of the program. The response rate to the letter of invitation to visit the hypertension clinic was 50%; 30% of the recall appointments were missed, and the dropout rate was 18.6%. Seventy percent of the hypertensive persons had Stage I disease (PAHO/WHO) with normal electrocardiograms. Before the program, 15.7% of the total number of hypertensive persons surveyed in the area had the disease under good control, and this increased to 31% after the program. Mortality due to cerebrovascular disease was reduced from 11/10,000/yr to 7/10,000/yr, whereas mortality caused by myocardial infarction did not change.

Entities:  

Mesh:

Year:  1988        PMID: 3346057     DOI: 10.1161/01.hyp.11.2_pt_2.i194

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  1 in total

1.  Performance of a Community-based Noncommunicable Disease Control Program in Korea: Patients 65 Years of Age or Older.

Authors:  Sun Mi Lim; Sung Hyo Seo; Ki Soo Park; Young Hwangbo; Yeonok Suh; Sungin Ji; Jeongmook Kang; Hyeonji Hwang; Jose Rene Bagani Cruz; Yoon Hyung Park
Journal:  J Korean Med Sci       Date:  2020-08-10       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.